ORLANDO, Florida — Use of cannabis is common in patients with multiple sclerosis (MS), especially for the treatment of MS-related spasticity, new research suggests. Findings from a survey conducted ...

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) said Tuesday that phase 3 RELEASE MSS1 trial, which evaluated nabiximols oromucosal spray on clinical measures of spasticity in individuals with multiple ...

Being diagnosed with multiple sclerosis can, naturally, have an enormous impact on your life. You may need to make some lifestyle changes and try a few treatments to help manage the various symptoms, ...

DUBLIN, June 28, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 3 RELEASE MSS1 trial (NCT04657666) evaluating nabiximols oromucosal spray ...

Credit: Getty Images. The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple sclerosis. Topline results were announced from a phase 3 trial evaluating the ...

Dec. 5 -- FRIDAY, Dec. 4 (HealthDay News) -- Cancer patients, glaucoma patients and others can benefit from medical marijuana, and now a new analysis shows that it can help multiple sclerosis (MS) ...